clinical trial · NCT05777031
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
University of Miami·phase4·recruiting·n = 22
Peyronie DiseaseSexual Dysfunctions, PsychologicalGenital Diseases, MaleCollagenase Clostridium Histolyticum (CCH)
brief summary
The purpose of this study is to learn about the safety and side effects of intralesional collagenase clostridium histolyticum (CCH) injected into the Peyronies Disease (PD) plaque after receiving prior treatment with intralesional Platelet Rich Plasma (PRP) injections.
started
Oct 2, 2023
primary completion
Jan 15, 2027
completion
Jan 15, 2027
last updated
Mar 23, 2026
official title
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional Platelet Rich Plasma for Peyronie's Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol